ICON PLC (ICLR) Stock Fundamental Analysis
NASDAQ:ICLR - IE0005711209 - Common Stock
165.44 USD
-3.5 (-2.07%)
165.44 USD
0 (0%)
ICLR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. ICLR has only an average score on both its financial health and profitability. ICLR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make ICLR a good candidate for value investing.
1. Profitability
1.1 Basic Checks
ICLR had positive earnings in the past year.
In the past year ICLR had a positive cash flow from operations.
Each year in the past 5 years ICLR has been profitable.
Each year in the past 5 years ICLR had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.78%, ICLR is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.31%, ICLR is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
ICLR has a Return On Invested Capital of 6.57%. This is in the better half of the industry: ICLR outperforms 74.55% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICLR is significantly below the industry average of 15.96%.
The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.57%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.78% | ||
| ROE | 8.31% | ||
| ROIC | 6.57% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
The Profit Margin of ICLR (9.82%) is better than 72.73% of its industry peers.
ICLR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 14.43%, ICLR is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
The Gross Margin of ICLR (28.65%) is worse than 76.36% of its industry peers.
In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.43% | ||
| PM (TTM) | 9.82% | ||
| GM | 28.65% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
Compared to 1 year ago, ICLR has less shares outstanding
The number of shares outstanding for ICLR has been increased compared to 5 years ago.
ICLR has a better debt/assets ratio than last year.
2.2 Solvency
ICLR has an Altman-Z score of 2.11. This is not the best score and indicates that ICLR is in the grey zone with still only limited risk for bankruptcy at the moment.
ICLR has a Altman-Z score (2.11) which is in line with its industry peers.
The Debt to FCF ratio of ICLR is 3.45, which is a good value as it means it would take ICLR, 3.45 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ICLR (3.45) is better than 76.36% of its industry peers.
ICLR has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
ICLR has a Debt to Equity ratio (0.35) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 3.45 | ||
| Altman-Z | 2.11 |
ROIC/WACC0.84
WACC7.85%
2.3 Liquidity
ICLR has a Current Ratio of 1.29. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
ICLR has a Current ratio of 1.29. This is amonst the worse of the industry: ICLR underperforms 81.82% of its industry peers.
A Quick Ratio of 1.29 indicates that ICLR should not have too much problems paying its short term obligations.
ICLR's Quick ratio of 1.29 is on the low side compared to the rest of the industry. ICLR is outperformed by 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for ICLR have decreased by -5.36% in the last year.
The Earnings Per Share has been growing by 15.23% on average over the past years. This is quite good.
Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.91% in the last year.
Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.36%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-13.07%
Revenue 1Y (TTM)-2.91%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%-4.85%
3.2 Future
ICLR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.25% yearly.
The Revenue is expected to grow by 2.36% on average over the next years.
EPS Next Y-3.09%
EPS Next 2Y1.71%
EPS Next 3Y4.15%
EPS Next 5Y7.25%
Revenue Next Year-3.02%
Revenue Next 2Y-0.67%
Revenue Next 3Y1.15%
Revenue Next 5Y2.36%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.50 indicates a correct valuation of ICLR.
Compared to the rest of the industry, the Price/Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.18% of the companies listed in the same industry.
ICLR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
Based on the Price/Forward Earnings ratio of 11.42, the valuation of ICLR can be described as reasonable.
Based on the Price/Forward Earnings ratio, ICLR is valued cheaper than 96.36% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.54. ICLR is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.5 | ||
| Fwd PE | 11.42 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 100.00% of the companies listed in the same industry.
ICLR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ICLR is cheaper than 94.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13 | ||
| EV/EBITDA | 10.42 |
4.3 Compensation for Growth
The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.82
EPS Next 2Y1.71%
EPS Next 3Y4.15%
5. Dividend
5.1 Amount
ICLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
165.44
-3.5 (-2.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners96.39%
Inst Owner Change-2.94%
Ins Owners0.65%
Ins Owner ChangeN/A
Market Cap12.87B
Analysts79.2
Price Target221.27 (33.75%)
Short Float %2.81%
Short Ratio1.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.05%
Min EPS beat(2)-0.34%
Max EPS beat(2)0.23%
EPS beat(4)1
Avg EPS beat(4)-3.93%
Min EPS beat(4)-14.41%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.35%
EPS beat(12)3
Avg EPS beat(12)-1.69%
EPS beat(16)6
Avg EPS beat(16)-1.11%
Revenue beat(2)0
Avg Revenue beat(2)-1.42%
Min Revenue beat(2)-2.61%
Max Revenue beat(2)-0.23%
Revenue beat(4)0
Avg Revenue beat(4)-2.78%
Min Revenue beat(4)-6.75%
Max Revenue beat(4)-0.23%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)0
Avg Revenue beat(12)-2.36%
Revenue beat(16)0
Avg Revenue beat(16)-2.13%
PT rev (1m)23.16%
PT rev (3m)21.57%
EPS NQ rev (1m)-0.22%
EPS NQ rev (3m)-6.74%
EPS NY rev (1m)0.32%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.5 | ||
| Fwd PE | 11.42 | ||
| P/S | 1.59 | ||
| P/FCF | 13 | ||
| P/OCF | 11.14 | ||
| P/B | 1.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.42 |
EPS(TTM)13.23
EY8%
EPS(NY)14.48
Fwd EY8.75%
FCF(TTM)12.73
FCFY7.69%
OCF(TTM)14.86
OCFY8.98%
SpS104.02
BVpS122.86
TBVpS-38.32
PEG (NY)N/A
PEG (5Y)0.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.78% | ||
| ROE | 8.31% | ||
| ROCE | 8.31% | ||
| ROIC | 6.57% | ||
| ROICexc | 6.76% | ||
| ROICexgc | 82.41% | ||
| OM | 14.43% | ||
| PM (TTM) | 9.82% | ||
| GM | 28.65% | ||
| FCFM | 12.23% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexcg growth 3Y-4.45%
ROICexcg growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 3.45 | ||
| Debt/EBITDA | 2.18 | ||
| Cap/Depr | 43.25% | ||
| Cap/Sales | 2.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.49% | ||
| Profit Quality | 124.6% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 2.11 |
F-Score5
WACC7.85%
ROIC/WACC0.84
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.36%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-13.07%
EPS Next Y-3.09%
EPS Next 2Y1.71%
EPS Next 3Y4.15%
EPS Next 5Y7.25%
Revenue 1Y (TTM)-2.91%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%-4.85%
Revenue Next Year-3.02%
Revenue Next 2Y-0.67%
Revenue Next 3Y1.15%
Revenue Next 5Y2.36%
EBIT growth 1Y3.81%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year1.32%
EBIT Next 3Y3.51%
EBIT Next 5Y4.07%
FCF growth 1Y160.15%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y116.49%
OCF growth 3Y15.78%
OCF growth 5Y25.55%